Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype
- PMID: 19997102
- PMCID: PMC2813761
- DOI: 10.1038/sj.bjc.6605484
Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype
Abstract
Background: Little is known about risk factors for childhood rhabdomyosarcoma (RMS) and the histology-specific details are rare.
Methods: Case-control studies formed by linking cancer and birth registries of California, Minnesota, New York, Texas and Washington, which included 583 RMS cases (363 embryonal and 85 alveolar RMS) and 57 966 randomly selected control subjects, were analysed using logistic regression. The associations of RMS (overall, and based on embryonal or alveolar histology) with birth weight across five 500 g categories (from 2000 to 4500 g) were examined using normal birth weight (2500-3999 g) as a reference. Large (>90th percentile) and small (<10th percentile) size for gestational age were calculated based on birth weight distributions in controls and were similarly examined.
Results: High birth weight increased the risk of embryonal RMS and RMS overall. Each 500 g increase in birth weight increased the risk of embryonal RMS (odds ratio (OR)=1.27, 95% confidence interval (CI)=1.14-1.42) and RMS overall (OR=1.18, 95% CI=1.09-1.29). Large size for gestational age also significantly increased the risk of embryonal RMS (OR=1.42, 95% CI=1.03-1.96).
Conclusions: These data suggest a positive association between accelerated in utero growth and embryonal RMS, but not alveolar RMS. These results warrant cautious interpretation owing to the small number of alveolar RMS cases.
Similar articles
-
Childhood rhabdomyosarcoma in Ibadan, Nigeria: 1984-2003.Ann Trop Paediatr. 2006 Dec;26(4):349-55. doi: 10.1179/146532806X152881. Ann Trop Paediatr. 2006. PMID: 17132301
-
Birth weight, fetal growth, and risk of pediatric rhabdomyosarcoma: an updated record linkage study in California.Ann Epidemiol. 2016 Feb;26(2):141-145. doi: 10.1016/j.annepidem.2015.11.007. Epub 2015 Dec 12. Ann Epidemiol. 2016. PMID: 26795698
-
Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.Cancer. 2009 Sep 15;115(18):4218-26. doi: 10.1002/cncr.24465. Cancer. 2009. PMID: 19536876 Free PMC article.
-
[Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].Pathologe. 2010 Mar;31(2):91-6. doi: 10.1007/s00292-009-1249-6. Pathologe. 2010. PMID: 19997735 Review. German.
-
Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature.Clin Neurol Neurosurg. 2020 May;192:105729. doi: 10.1016/j.clineuro.2020.105729. Epub 2020 Feb 6. Clin Neurol Neurosurg. 2020. PMID: 32058205 Review.
Cited by
-
Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.Cancer Med. 2015 May;4(5):781-90. doi: 10.1002/cam4.448. Epub 2015 Mar 23. Cancer Med. 2015. PMID: 25809884 Free PMC article.
-
Magnitude of fetal macrosomia and its associated factors at public health institutions of Hawassa city, southern Ethiopia.BMC Res Notes. 2018 Dec 13;11(1):888. doi: 10.1186/s13104-018-4005-2. BMC Res Notes. 2018. PMID: 30545390 Free PMC article.
-
Childhood rhabdomyosarcoma: new insight on biology and treatment.Curr Oncol Rep. 2010 Nov;12(6):402-10. doi: 10.1007/s11912-010-0130-3. Curr Oncol Rep. 2010. PMID: 20820958 Review.
-
Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group.Int J Cancer. 2014 Jan 15;134(2):431-6. doi: 10.1002/ijc.28363. Epub 2013 Aug 1. Int J Cancer. 2014. PMID: 23824786 Free PMC article.
-
Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group.Cancer Causes Control. 2014 Jul;25(7):905-13. doi: 10.1007/s10552-014-0390-6. Epub 2014 May 16. Cancer Causes Control. 2014. PMID: 24831857 Free PMC article.
References
-
- Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, Filocamo M, Kato K, Suzuki Y, Kure S, Matsubara Y (2005) Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37: 1038–1040 - PubMed
-
- Caughey RW, Michels KB (2009) Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 124: 2658–2670 - PubMed
-
- Chellakooty M, Vangsgaard K, Larsen T, Scheike T, Falck-Larsen J, Legarth J, Andersson AM, Main KM, Skakkebaek NE, Juul A (2004) A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 89: 384–391 - PubMed
-
- Dagher R, Helman L (1999) Rhabdomyosarcoma: an overview. Oncologist 4: 34–44 - PubMed
-
- Das UG, Sysyn GD (2004) Abnormal fetal growth: intrauterine growth retardation, small for gestational age, large for gestational age. Pediatr Clin North Am 51: 639–654, viii - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources